For instance, the levels of MMP‐2 and MMP‐9 are significantly elevated in patients with AAA, particularly MMP‐9, which has been shown to degrade collagen and elastin in the ECM, leading to arterial wall weakening and the promotion of aneurysm formation. Here, MMP2 is linked to triple-A syndrome.